当前位置: X-MOL 学术Travel Med. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Gastrointestinal basidiobolomycosis: An emerging mycosis difficult to diagnose but curable. Case report and review of the literature.
Travel Medicine and Infectious Disease ( IF 6.3 ) Pub Date : 2019-01-17 , DOI: 10.1016/j.tmaid.2019.01.013
Maria Diletta Pezzani 1 , Valentina Di Cristo 1 , Carlo Parravicini 2 , Angelica Sonzogni 3 , Cristina Tonello 2 , Marco Franzetti 4 , Salvatore Sollima 4 , Mario Corbellino 4 , Massimo Galli 5 , Laura Milazzo 4 , Spinello Antinori 5
Affiliation  

Background

Gastrointestinal basidiobolomycosis (GIB) is a rare mycosis affecting almost exclusively immunocompetent subjects.

Methods

We describe a case of GIB caused by Basidiobolus ranarum in a 25-year-old Italian immunocompetent man resident in Ireland who presented a 2-month history of epigastric pain. Suspecting colon cancer he underwent a right hemicolectomy subsequently leading to a diagnosis of GIB by means of molecular biology. After surgery a 9-month therapy with itraconazole was employed with a good outcome. A review of medical literature regarding GIB cases published in the period 1964–2017 is presented.

Results

One-hundred and two cases of GIB were included in this analysis. The disease was observed predominantly in male gender (74.5%) and children (41.2%). Abdominal pain was the single most common complaint (86.3%) followed by fever (40.2%) and evidence of an abdominal mass (30.4%). Peripheral blood eosinophilia was detected in 85.7% of cases. Most of the patients were diagnosed in Saudi Arabia (37.2%) followed by USA (21.6%) and Iran (20.6%). Surgery plus antifungal therapy was employed in the majority of patients (77.5%). An unfavourable outcome was documented globally in 18.6% of patients.

Conclusions

GIB seems to be an emerging intestinal mycosis among immunocompetent patients living in the Middle East and Arizona.



中文翻译:

胃肠道真菌病:一种难以诊断但可以治愈的新兴真菌病。病例报告和文献复习。

背景

胃肠道芽孢杆菌病(GIB)是一种罕见的真菌病,几乎只影响具有免疫能力的受试者。

方法

我们描述了一个由Basidiobolus ranarum引起的GIB病例,该病例发生在居住在爱尔兰的25岁意大利具有免疫能力的男子中,该男子出现了2个月的上腹痛史。怀疑结肠癌,他接受了右半结肠切除术,随后通过分子生物学诊断为GIB。手术后,使用伊曲康唑治疗9个月,效果良好。本文介绍了1964-2017年间发表的有关GIB病例的医学文献。

结果

该分析包括一百零二例GIB病例。该病主要在男性(74.5%)和儿童(41.2%)中观察到。腹痛是最常见的主诉(86.3%),其次是发烧(40.2%)和腹部有肿块(30.4%)。在85.7%的病例中检测到外周血嗜酸性粒细胞增多。大多数患者被诊断为沙特阿拉伯(37.2%),其次是美国(21.6%)和伊朗(20.6%)。大多数患者(77.5%)采用手术加抗真菌治疗。全球18.6%的患者记录了不良结果。

结论

在居住在中东和亚利桑那州的具有免疫能力的患者中,GIB似乎是一种新兴的肠道真菌病。

更新日期:2019-01-17
down
wechat
bug